🇺🇸 Gliclazide MR and Insulin Glargine Injection in United States

Gliclazide MR and Insulin Glargine Injection (Gliclazide MR and Insulin Glargine Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Gliclazide MR and Insulin Glargine Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Gliclazide MR and Insulin Glargine Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Gliclazide MR and Insulin Glargine Injection in United States?

Servier (Tianjin) Pharmaceutical Co. LTD. is the originator. The local marketing authorisation holder may differ — check the official source linked above.